semaglutide vs mounjaro weight loss vs. Wegovy: The 2026 Guide for Asian Bodies & Thai Patients - Siam Clinic Semaglutide vs Ozempic vs Wegovy

When patients respond inadequately to one GLP-1 agent, data now supports switching to or adding the complementary GLP-1/GIP dual agonist (tirzepatide) rather than introducing a second drug class like phentermine

In the new partnership with Penn Medicine, Cubans company will source generic drugs from pharmaceutical manufacturing companies at lower costs and with fewer hurdles, officials said

Recent studies have provided consistent evidence on the association of hyperuricemia with adverse outcomes, primarily with the increased risk of mortality in patients with HF

Wegovy, Ozempic and Eli Lilly's Mounjaro and Zepbound belong to a class of therapies known as GLP-1 receptor agonists originally developed to control blood sugar in patients with type 2 diabetes

Transl Psychiatry 8, 242 (2018)